Unknown

Dataset Information

0

New Zampanolide Mimics: Design, Synthesis, and Antiproliferative Evaluation.


ABSTRACT: Zampanolide is a promising microtubule-stabilizing agent (MSA) with a unique chemical structure. It is superior to the current clinically used MSAs due to the covalent nature of its binding to ?-tubulin and high cytotoxic potency toward multidrug-resistant cancer cells. However, its further development as a viable drug candidate is hindered by its limited availability. More importantly, conversion of its chemically fragile side chain into a stabilized bioisostere is envisioned to enable zampanolide to possess more drug-like properties. As part of our ongoing project aiming to develop its mimics with a stable side chain using straightforward synthetic approaches, 2-fluorobenzyl alcohol was designed as a bioisosteric surrogate for the side chain based on its binding conformation as confirmed by the X-ray structure of tubulin complexed with zampanolide. Two new zampanolide mimics with the newly designed side chain have been successfully synthesized through a 25-step chemical transformation for each. Yamaguchi esterification and intramolecular Horner-Wadsworth-Emmons condensation were used as key reactions to construct the lactone core. The chiral centers at C17 and C18 were introduced by the Sharpless asymmetric dihydroxylation. Our WST-1 cell proliferation assay data in both docetaxel-resistant and docetaxel-naive prostate cancer cell lines revealed that compound 6 is the optimal mimic and the newly designed side chain can serve as a bioisostere for the chemically fragile N-acetyl hemiaminal side chain in zampanolide.

SUBMITTER: Chen G 

PROVIDER: S-EPMC7024368 | biostudies-literature | 2020 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

New Zampanolide Mimics: Design, Synthesis, and Antiproliferative Evaluation.

Chen Guanglin G   Jiang Ziran Z   Zhang Qiang Q   Wang Guangdi G   Chen Qiao-Hong QH  

Molecules (Basel, Switzerland) 20200115 2


Zampanolide is a promising microtubule-stabilizing agent (MSA) with a unique chemical structure. It is superior to the current clinically used MSAs due to the covalent nature of its binding to <i>β</i>-tubulin and high cytotoxic potency toward multidrug-resistant cancer cells. However, its further development as a viable drug candidate is hindered by its limited availability. More importantly, conversion of its chemically fragile side chain into a stabilized bioisostere is envisioned to enable z  ...[more]

Similar Datasets

| S-EPMC6555766 | biostudies-literature
| S-EPMC9822352 | biostudies-literature
| S-EPMC9104188 | biostudies-literature
| S-EPMC5130025 | biostudies-literature
| S-EPMC6071795 | biostudies-literature
| S-EPMC8979089 | biostudies-literature
| S-EPMC5314971 | biostudies-literature
| S-EPMC6271626 | biostudies-literature
| S-EPMC5891370 | biostudies-other
| S-EPMC9327782 | biostudies-literature